Member access

4-Traders Homepage  >  Shares  >  Nyse  >  AbbVie Inc    ABBV   US00287Y1091

ABBVIE INC (ABBV)

40
Delayed Quote. Delayed Nyse - 08/22 01:26:10 pm
55.07 USD   +0.20%
6h ago ABBVIE : Assigned Patent
1d ago ABBVIE : Entry into a Material Definitive Agreement, Creation of a Direct F..
1d agoDJU.S. Restricts Narcotic Pain Drug Prescriptions
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
08/18/2014 08/19/2014 08/20/2014 08/21/2014 08/22/2014 Date
54.31(c) 55.29(c) 55.06(c) 54.96(c) 55.07 Last
7 370 618 9 160 272 7 612 618 8 063 190 6 093 778 Volume
+0.76% +1.80% -0.42% -0.18% +0.20% Change
More quotes
Company
AbbVie, Inc. is a research-based biopharmaceutical company. It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products. The company's products are used to treat rheumatoid arthritis, psoriasis, Crohn's disease, HIV, cystic fibrosis... 
Sector
Pharmaceuticals
Calendar
10/24Earnings Release
Surperformance© rating of AbbVie Inc
Trading Rating : Investor Rating :
More about the company
Chart ABBVIE INC
Duration : Period :
AbbVie Inc Technical Analysis Chart | ABBV | US00287Y1091 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 19 630 M
EBIT 2014 6 853 M
Net income 2014 4 722 M
Debt 2014 4 755 M
Yield 2014 3,00%
Sales 2015 21 714 M
EBIT 2015 8 606 M
Net income 2015 6 011 M
Debt 2015 1 500 M
Yield 2015 3,27%
PER 2014 19,38
PER 2015 13,32
EV / Sales 2014 4,71x
EV / Sales 2015 4,11x
Capitalization 87 675 M
More Financials
Latest news on ABBVIE INC
6h ago ABBVIE : Assigned Patent
1d ago ABBVIE : Entry into a Material Definitive Agreement, Creation of a Direct Financ..
1d agoDJU.S. Restricts Narcotic Pain Drug Prescriptions
1d agoDJInversions Push Falls to Treasury's Mark J. Mazur
1d agoDJDEA Restricts Narcotic Pain Drug Prescriptions
1d ago ABBVIE : Cystic Fibrosis Scholarship Program Provides 40 Student Scholars with A..
4d ago ABBVIE : Cystic Fibrosis Scholarship Program Awards 40 Student Scholars With Ann..
4d ago ENANTA PHARMACEUTICALS : Updates on 3rd Quarter Financial Results
7d ago ABBVIE : INVESTOR ALERT: Investigation of AbbVie Inc. Announced by The Wagner Fi..
08/15DJU.K. Drug Panel Backs Gilead's Hepatitis Drug at a Discount
08/15 U.S. investors switch out of Europe as recovery bet sours
08/15 ABBVIE : Assigned Patent
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Technical analysis
Income Statement Evolution
AbbVie Inc : Income Statement Evolution
More Financials
EPS Revisions
AbbVie Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF